Scancell is developing novel therapeutic vaccines for the treatment of cancer and infectious diseases. Scancell’s first cancer vaccine SCIB1 is being developed for the treatment of melanoma and is in Phase I clinical trials.
|Annual Report 2011||30-04-2011||30-06-2011|
|Annual Report 2010||30-04-2010||13-07-2010|
|Annual Report 2009||30-04-2009||01-01-1970|
|Interim Report 2010||31-10-2010||31-01-2011|
|Interim Report 2009||31-10-2009||29-01-2010|